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HSP72 is dramatically induced in the ovaries of vaccinia virus (VV)-infected mice and associates with VV proteins. In
order to investigate the role of HSP72 during vaccinia virus replication, we have constructed a recombinant vaccinia virus
encoding the major inducible cellular HSP72 (VV-HSP72/) and examined the replication characteristics of this virus. VV-
HSP72/ exhibited growth kinetics identical to and peak titers very similar to those of control viruses, both in vitro and in
vivo. In particular, replication of VV-HSP72/was identical to that of control viruses in the HSP72-negative cell line Y3.Ag.1.2.3,
and overexpression of HSP72 had no effect on the virulence of VV infection in normal or immunocompromised mice. We
conclude that while VV infection results in the induction of the major inducible 72-kDa HSP, VV replication proceeds normally
in the absence of this protein. It is unclear whether another celluar chaperone is required to facilitate virus replication in
place of HSP72 in Y3.Ag.1.2.3 cells or whether HSP expression plays no role in virus replication, but is simply a component
of the generalized stress response to virus infection. q 1996 Academic Press, Inc.
significant homology to DnaJ (a cellular HSP40 homo-The elevated expression of stress proteins or heat
logue) (22) and certain closteroviruses which encodeshock proteins (HSP) has been described in a number
HSP70 homologues (23–25). In prokaryotic systems, bac-of different cells after infection by a variety of eukaryotic
terial HSPs have been clearly shown to be critical forviruses (1 – 5). While both the mechanism(s) of HSP in-
productive bacteriophage infection. For example, stressduction during virus infection and the subsequent role(s)
proteins DnaK (70-kDa HSP), DnaJ (40-kDa HSP), andHSPs play during infection remain mostly unknown,
GrpE (a 22-kDa dimer) are essential for replication ofsome have speculated that the function of HSPs ex-
bacteriophage l DNA in Escherichia coli (26, 27 ), andpressed during virus infection is to act as molecular
GroEL (an HSP60 homologue) together with its acces-chaperones, facilitating the correct folding and/or assem-
sory protein GroES (a 10-kDa HSP) is crucial for correctbly of viral proteins (6, 7 ). Clearly, many stress proteins
morphogenesis and assembly of bacteriophages l, T4,function as molecular chaperones to assist correct pro-
and T5 (26, 28). The bacteriophage T4 also encodes atein folding (8), translocation across intracellular mem-
cochaperonin which can substitute for GroES (29). How-branes (9), and assembly of multmeric protein complexes
ever, for eukaryotic viruses there exist only few examples(for reviews see 10 – 12). That stress protein expression
where stress proteins have been observed to facilitateis increased during virus infection and that many of these
the processing of particular viral proteins. A nascent viralHSPs can associate with viral proteins (13–21) support
glycoprotein from vesicular stomatitis virus (VSV) (30, 31)this hypothesis. Moreover, some viruses have been
and human cytomegalovirus (32) transiently associatesshown to encode sequences with significant homology
with calnexin, during transit and processing through theto stress proteins, including the poxvirus Molluscum con-
ER, and monomeric forms of the influenza hemagglutinintagiosum which encodes an open reading frame with
molecule (33), as well as the VSV glycoprotein, have been
observed to associate transiently with the glucose-re-
sponsive protein GRP78 or BiP. However, there is no1 To whom correspondence and reprint requests should be ad-
evidence that such interactions are necessary require-dressed at present address: Department of Biochemistry, University of
Alberta, Edmonton, Alberta T6G 2H7, Canada. Fax: (1-403) 492 9556. ments for productive eukaryotic virus replication.
E-mail: Lisa Sedger@darwin.biochem.ualberta.ca. We have previously shown that HSP72 is dramatically
2 Present address: Cell Transformation Group, Pathology Depart- induced in the ovaries of vaccinia virus (VV)-infected mice
ment, University of Otago Medical School, Box 913, Dunedin, New
(5). Furthermore, HSP72 associates with VV proteins,Zealand.
since HSP72 can be coimmunoprecipitated together with3 Present address: Department of Microbiology, University of Mel-
bourne, Parkville, Vic. 3052, Australia. VV proteins (17 ). Although the precise function(s) of the
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highly stress inducible HSP72 has not been definitively
shown, it has been attributed functions similar to those
of the constitutively expressed 73-kDa HSP due to exten-
sive nucleotide and amino acid homology and biochemi-
cal properties. That these two proteins have been evolu-
tionarily conserved in most cells, suggests, however, that
HSP72 possesses characteristics both similar to and
unique from those of HSP73. In this study, we have at-
tempted to address whether cellular HSP72, the most
abundant stress protein expressed during VV infection,
functions to facilitate poxvirus replication. First, we have
overexpressed HSP72 during VV infection in vitro and in
vivo. Second, we have assessed virus replication in
HSP72-deficient cells in the presence or absence of vi-
rus-expressed HSP72.
In order to assess the influence of murine HSP72 on
virus replication, a recombinant VV was engineered to
encode the major murine heat-inducible HSP72 gene
(34 ). Murine HSP72 cDNA was amplified by PCR and
cloned into the SmaI site of the VV thymidine kinase-
insertion vector pSC11 (35) in either 5*-3* sense or 3*-5*
anti-sense orientation, immediately downstream of the
p7.5 early/late poxvirus promoter. Sequence analysis of
both strands of the PCR product revealed one nucleotide
change from the published sequence (34 ) corresponding
to an amino acid substitution from arginine to threonine
at residue 5. This is a highly divergent region in HSP70
family proteins, and given that the threonine is fairly simi-
lar to other residues found at this position, while other
HSP72 homologues have quite dissimilar amino acids at
this position, we consider it unlikely to alter function.
Recombinant VV were constructed by homologous re-
combination with the L929 cell-adapted WR strain of wild-
type vaccinia virus (36) using standard techniques (37 ).
These viruses were designated VV-HSP72/ (5*-3*), VV-
HSP720 (3*-5*), and VV-pSC11 (vector only). To test for FIG. 1. Western immunoblot analysis of HSP72 expression and virus
replication 24 hr p.i. with VV-HSP72/ VV-HSP720, or VV-pSC11 in L929HSP72 expression by the recombinant VV, murine L929
cells (A and B) and HSP72-deficient Y3-Ag.1.2.3 (Y3) cells (C and D).cells were infected with each of the recombinant VV and
Lysates were prepared from 106 cells per sample, 24 hr p.i. at the m.o.i.were harvested 24 hr postinfection (p.i.), and cell lysates
shown, and HSP72 was detected using HSP72-specific antibody C92,
were prepared and examined by Western immunoblot- as described previously (5). HSP72 expression in control uninfected
ting using the anti-HSP72 antibody C92F3A5 (StressGen cells (CO) and after heat shock for 2 hr at 427 (HS) is also shown. Virus
replication, 24 hr p.i., was determined by titrating virus from lysates ofBiotechnologies Corp., Victoria, Canada) as described
L929 cells or Y3 cells (106 cells per sample) on human 143B cells. Thepreviously (5). Murine L929 cells infected with VV-
limit of detection of 102 PFU in the virus plaque assay is indicatedHSP72/ expressed abundant HSP72 compared to cells
by the dotted line, and the data shown are representative of repeat
infected with control construct VV-HSP720 or VV-pSC11 experiments.
(Fig. 1A). Western immunoblot analysis of lysates from
L929 cells infected with VV-HSP720 indicated that this
3*-5* antisense construct did not block cellular HSP72 infection (m.o.i.), the extent of virus replication by 24 hr
p.i. was found to be similar to that of control viruses VV-induced by VV infection (Fig. 1A), which could be due to
a variety of factors (38). As expected, cellular HSP72 HSP720 or VV-pSC11 (Fig. 1B). Since infection by control
viruses induced cellular HSP72 in L929 cells (Fig. 1A),induced by VV infection was also detected in L929 cell
lysates from VV-pSC11-infected cultures (Fig. 1A). the effect of HSP72 expression on VV growth was also
assessed in an HSP72-deficient rat myeloma cell line,We then examined whether the abundant expression
of HSP72 influenced viral replication by titrating virus Y3-Ag.1.2.3 (39), denoted here as Y3 cells. These cells
did not express HSP72 after heat shock (40) (Fig. 2A),production on 143B cells. When murine L929 cells were
infected with VV-HSP72/ at a range of multiplicities of and unlike L929 cells, infection of Y3 cells with VV-pSC11
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VV-HSP720 replication in HSP72-defective Y3 cells (Fig.
2). Since HSPs also play an important role in the quality
control mechanisms of normal and abnormal protein fold-
ing and processing, the morphogenesis of virus particle
formation from early through to late times p.i. was exam-
ined at an ultrastructural level using scanning electron
microscopy. Y3 cells were infected with VV-HSP72/ or
VV-HSP720 at a m.o.i. of 5 PFU/cell, and then cells were
washed and incubated for various times through to 24
hr p.i. No differences in virus particle formation or the
morphology of Y3 cells infected with VV-HSP72/ or VV-
HSP720 were observed (data not shown). Together,
these results indicate that VV replication proceeded nor-
mally at all times throughout infection irrespective of the
presence or absence of HSP72.
Next, we investigated the growth of the recombinant
VV encoding HSP72 in vivo. Replication of VV-HSP72/
was compared to that of VV-HSP720 and VV-pSC11 in
the ovaries of infected mice, since VV normally grows to
very high titers in these organs (41, 42). VV-HSP72/ grew
to peak titers of 107.5 PFU in murine ovarian tissue by 6
days p.i., similar to VV-pSC11 and VV-HSP720 (Fig. 3).
Furthermore, the kinetics of VV-HSP72/ replication and
clearance from murine ovarian tissue was identical to
that of control viruses (Fig. 3). Since mouse ovarian tissue
contains high levels of mRNA for the transcription factor
responsible for inducible HSP72 expression, muHSF1
(43), we also looked at the ability of these viruses to
grow in the liver, where muHSF1 mRNA was not detected
FIG. 2. Kinetics of virus growth in Y3 cells. Replication of VV-HSP72/,
VV-HSP720, and VV-pSC11 in HSP72-deficient Y3-Ag.1.2.3 (Y3) cells,
infected at m.o.i. of 10 (A), 1 (B), or 0.1 (C). Virus replication was deter-
mined by titrating virus from lysates of Y3 cells (106 cells per sample)
taken at various times p.i., on human 143B cells. Data shown are
representative of repeat experiments.
or VV-HSP720 did not result in expression of cellular
HSP72 (Fig. 1C). Hence, neither heat shock nor VV infec-
tion induced HSP72 in Y3 cells. Infection of Y3 cells with
VV-HSP72/ resulted in abundant production of virus-
encoded HSP72 24 hr after infection (Fig. 1C). However,
VV-HSP72/ and the control constructs, VV-HSP720 and FIG. 3. Growth of HSP72 viruses in normal mice. Kinetics of VV-
VV-pSC11, grew to identical titers, irrespective of the HSP72/, VV-HSP720, and VV-pSC11 replication in the ovaries of nor-
mal CBA mice. Specific pathogen-free female CBA-H mice were ob-presence or absence of HSP72 or the m.o.i. (Fig. 1D). In
tained from the Animal Breeding Establishment at the JCSMR. Groupsorder to define whether HSP72 influences early events
of 5 female mice were infected with 107 PFU of virus iv, and virusduring virus infection, we also looked for differences in
replication was measured by titration of ovary homogenates on human
virus replication from the onset of infection through to 143B cells. Data shown are means of log10 PFU/pair of ovaries { SEM
24 hr p.i. At all times investigated, we found that VV- of 5 mice. The limit of detection of 102 PFU in this plaque assay is
indicated by the dotted line.HSP72/ replication was very similar to VV-pSC11 and
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TABLE 1 protein assembly and virus morphogenesis. Alternatively,
HSP expression may simply be a part of the generalizedGrowth of HSP72-Encoding Vaccinia Virus in Nude Micea
stress response to virus infection and play no role in
Virusa Titer b % Mortality MTDc virus replication. Our study indicates that overexpression
of HSP72 within the virus-infected cell did not detectably
VV-pSC11 7.35 { 0.50 ND ND alter VV replication. Thus, the interactions of HSPs with
VV-HSP72/ 7.40 { 0.45 100 14.0 (12, 13, 14, 15, 16)
VV proteins demonstrated by others (18) may be interpre-VV-HSP720 7.38 { 0.65 100 13.6 (12, 14, 14, 14, 14)
ted to reflect normal physiological events, such that a
a Female Swiss outbred nude mice (nu/nu), 8–10 weeks old, were plentiful supply of HSP70 with inherent affinity for nonna-
obtained from the Animal Breeding Establishment at the John Curtin tive protein would be highly likely to interact with abun-
School of Medical Research. Ten mice per group were infected iv with dant nascent viral proteins which are present in the same
106 PFU or recombinant vaccinia virus VV-pSC11, VV-HSP72/, or VV-
cellular compartment. The fact that we found no differ-HSP720. Five mice were sacrificed 4 days p.i. for determination of
ences in the replication of these HSP72 recombinantvirus titers from ovary tissue homogenates, titrated on human 143B
cells. The remaining five mice were used for assessment of mortality vaccinia viruses does not discount the possibility that
due to virus disease. ND, not tested. HSP72 can influence other subtle factors not reflected
b Data shown are means log10 PFU/pair of ovaries { SEM of 5 mice, by viral titers. For example, the requirements for correct
4 days p.i. The limit of detection in this assay is 102 PFU.
viral protein folding may be energetically more expensivec MTD, mean time of death, days p.i.
without HSP72 participating in the folding process.
In interpreting our data, it may be important to consider
that HSP genes exist as multigene families. For example,(43) and where VV does not normally grow to high titers
(41, 42). Titration of liver homogenates from mice infected there have been estimated to be at least 8 functional
human HSP70 family genes (45–48) and a similar num-i.p. with 108 PFU of either VV-HSP72/ or VV-HSP720
revealed that both viruses replicated to very similar levels ber in mice (34, 49). It is not known to what extent func-
tional redundancy exists within this family of heat shockin this tissue, reaching peak titers of 104 PFU by 2 days
p.i. and decreasing to approximately 103 PFU by Day 4 proteins, and although there is clearly no expression of
HSP72 in Y3 cells, it may be significant that detectable(data not shown). Hence the overexpression of HSP72
by the recombinant VV did not alter the level of virus levels of the constitutively expressed 73-kDa HSP can
be found in these cells before and after VV infection (datareplication in the ovaries or livers of normal mice.
Finally, we investigated virus replication and disease not shown). It is possible that HSP73 or another HSP70
family member may functionally compensate for the lackprogression in T-cell-deficient nude mice, which normally
cannot control VV replication and die (41, 44 ). By 4 days of HSP72 in Y3 cells. If in fact HSP72 does influence
virus replication, redundancy in function of HSP70 familyp.i., VV-HSP72/ grew to the same titer as VV-HSP720
and VV-pSC11 in the ovaries of these mice (Table 1). proteins may mean that it is impossible to delineate the
role of HSP72 in vaccinia virus infection, using theseConsistent with this finding, there was also no difference
in the mean time of death of nude mice similarly infected systems. For example, it is possible that HSP70 proteins
are important for sequestering aberrantly folded viral pro-with VV-HSP72/ or VV-HSP720, since mice infected with
either virus died by Day 13 or 14 p.i. (Table 1). Therefore, teins, to preclude their packaging into mature virions,
whilst optimizing functional viral protein expression. Onoverexpression of HSP72 did not influence the growth of
VV or the virulence of infection in immunocompromised the other hand, the presence of functional copies of both
HSP72 and HSP73 in most cells argues that HSP72 maynude mice.
The demonstration that HSP72 stress proteins are ex- feature properties distinct from HSP73, and notably it is
the expression of HSP72 which has been demonstratedpressed in abundance in virus-infected cells (5), can tran-
siently associate with viral proteins (18), and are im- to be dramatically upregulated in VV-infected tissues in
mice (5). In this paper, we have demonstrated that VV-portant cofactors for prokaryotic virus replication (26–29)
suggests that cellular HSPs play an important role during HSP72/ replication was identical to that of control con-
structs, irrespective of the m.o.i. used for in vitro studiespoxvirus replication. That some viruses encode open
reading frames homologous to cellular HSPs (22–25) and the time postinfection or target tissue examined in
infected mice. We conclude that while we have pre-adds further support to this hypothesis. However, this
evidence remains circumstantial, and although examples viously shown that VV infection results in the induction
of the major inducible 72-kDa HSP, VV replication occursexist where certain HSPs and chaperonins have been
demonstrated to participate in the processing of particu- normally in the absence of this protein. It is unclear
whether another celluar chaperone is required to func-lar eukaryotic virus-encoded glycoproteins (30–33), there
remains very little evidence that this is an important or tion in place of HSP72 in Y3 cells or whether HSP expres-
sion plays no role in virus replication, but is simply anecessary requirement for viral replication. It is possible
that interactions between HSPs and viral proteins may component of the generalized stress response to virus
infection.either facilitate virus protein maturation or inhibit viral
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